908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer, the Rebel™. This first-of-its-kind, miniature CE-MS-based analyzer lets biopharma researchers accelerate process development cycles and maximize their bioreactor utilization by running media analysis at-line, anytime. The company is presenting the Rebel for the first time at the Bioprocessing Summit in Boston, August 12-16.

Biotherapeutics are produced by live cells that require cell culture media to develop properly.  Their growth is dynamic and needs to be monitored regularly.  Media analysis is routinely performed by a core lab or 3rd-party service provider, but the typical two-to-three week turnaround time prevents any real-time decision making by bioprocess engineers.  The Rebel puts control in the bioprocess researcher’s hands.  Its small, self-contained footprint fits alongside bioreactors in process development and cell culture labs. Samples can be run at-line in less than 7 minutes, completely eliminating the core lab wait time.  It takes calibration and data analysis off the scientists’ plate completely, providing quantitative identification and analysis on a panel of >30 analytes including all the key amino acids, biogenic amines, water soluble vitamins and dipeptides. The Rebel is built for cGLP/cGMP environments, integrating reporting, automated performance qualification and 21 CFR Part 11-compliant software.

“We’re focused on building disruptive products that enable customers to make critical decisions when and where they need to,” said Dr. Kevin J. Knopp, CEO and Co-founder of 908 Devices. “The Rebel does just that by equipping biopharma PD labs, or pretty much anyone who cultures cells and uses cell media, with immediate answers. It provides a solution for the common struggle all early-stage biopharma candidate programs experience, and helps them bring promising therapeutics to market faster.”

908 Devices scientists are presenting a talk titled Rapid At-line Spent Media Analysis with a New Integrated Benchtop Analyzer Disrupts the Antiquated Core Lab Model and posters at the Bioprocess Summit, giving researchers first-hand info on how easily they can integrate the Rebel into their current bioprocesses. The company is also hosting a launch party at their Boston headquarters just blocks away on Tuesday evening, August 13. Show attendees can have a fun evening out with good food and music, get expert tutorials and hands-on time with the device, and check out the company’s brand-new facility. For anyone that can’t make the Bioprocess Summit, 908 Devices will also be showcasing this new product at the Bioprocess International convention September 9-12 in Boston.